AnalystsAllison Bratzel
Allison Bratzel's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 11%
#511 out of 5014 analysts
Average Return
+27.52%
Win Rate
71%24 out of 34
Risk vs Reward
Poor
Good

Allison Bratzel's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inozyme Pharma IncINZY
+277.36%$1.06$4.00
2025-03-11 -
2025-07-01
Strong Buy
Scholar Rock Holding CorpSRRK
+121.87%$15.00$33.28
2024-03-26 -
2025-03-25
Strong Buy
Scholar Rock Holding CorpSRRK
+86.26%$8.44$15.72
2023-04-03 -
2024-04-02
Strong Buy
Vectivbio Holding AgVECT
+77.37%$9.50$16.85
2023-04-20 -
2023-07-07
Strong Buy
Argenx SeARGX
+76.16%$354.13$623.82
2023-12-21 -
2024-12-20
Strong Buy

Allison Bratzel's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Argenx SeARGX
14Strong Buy$820.00+8.41%Maintains
19 days ago
Ionis Pharmaceuticals IncIONS
2Strong Buy$65.00+2.91%Maintains
23 days ago
Abivax SaABVX
1Strong Buy$112.00+33.32%Maintains
2 months ago
Replimune Group IncREPL
2Strong Buy$22.00+283.94%Maintains
3 months ago
Tyra Biosciences IncTYRA
1Strong Buy$33.00+163.58%Assumes
4 months ago
Ultragenyx Pharmaceutical IncRARE
1Strong Buy$115.00+279.41%Maintains
6 months ago
Akebia Therapeutics IncAKBA
1Strong Buy$6.00+103.39%Maintains
6 months ago
Inozyme Pharma IncINZY
1Strong Buy$23.00+475.00%Maintains
6 months ago
Engene Holdings IncENGN
1Strong Buy$26.00+355.34%Initiates Coverage On
7 months ago
Travere Therapeutics IncTVTX
2Hold$22.00-6.26%Maintains
10 months ago
Rigel Pharmaceuticals IncRIGL
2Hold$23.00-39.41%Maintains
10 months ago
Scholar Rock Holding CorpSRRK
3Strong Buy$42.00+32.62%Maintains
a year ago
Roivant Sciences LtdROIV
2Strong Buy$22.00N/AMaintains
a year ago
Humacyte IncHUMA
2Hold$4.00N/AMaintains
a year ago
Solid Biosciences IncSLDB
4Strong Buy$20.00N/AUpgrades
2 years ago
Abcellera Biologics IncABCL
1Strong Buy$20.00N/AAssumes
2 years ago
Vectivbio Holding AgVECT
1Strong Buy$25.00N/AMaintains
2 years ago
Incyte CorpINCY
2Strong Buy$100.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.